483
GLPGCP Development (Asia) Pte. Ltd.GLPGCP Development (Asia) Pte. Ltd. – FDA 483, Aug 3, 2017
Record Details
An FDA inspection of TELEMED, a manufacturer in Vilnius, Lithuania, from July 31 to August 3, 2017, identified 18 significant deficiencies. The observations highlight a widespread lack of established procedures across critical quality system areas, including complaint handling, design control, process control, and training. This indicates a fundamental breakdown in the firm's quality management system.
View Company Profile
ID · 50a62d71-bc66-4dc8-8812-78e3e9f52204
Other documents for GLPGCP Development (Asia) Pte. Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.